NASDAQ
Kairos Pharma, Ltd. (KAPA) has a market cap of $11.62M as of Thursday, May 21, 2026. The KAPA market cap is down 4.03% over the past 30 days and has grown 26.40% over the past year. Market capitalization represents the total market value of a company's outstanding shares, calculated by multiplying the stock price by the total number of shares outstanding.
No price data available for this timeframe.